ARCHIVES

Senate Authorizes $30 Million For Childhood Cancer Clinical Trials Research.

This article is from The Cancer Letter archive.

Vol. 34 No. 28 | July 18, 2008

Download PDF Visit The Full Archive

Related Articles

Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival

March 28, 2014

Part II of Q&A With NCI Director Harold Varmus

July 29, 2011

Masons Give $65 Million to Univ. of Minnesota Cancer Center.

April 25, 2008

RAS Mutations Can Predict Resistance To Vectibix, FOLFOX Combination Treatment

September 27, 2013

Poll Finds Voters Support Doubling Of Research Funds.

November 3, 2000

NCI Cancer Education Program To Open To Innovative Ideas

April 2, 1993